Home › Funds › Trails Edge Capital Partners, LP › MLTX

Trails Edge Capital Partners, LP position in MLTX

MOONLAKE IMMUNOTHERAPEUTICS · Health Care

Trails Edge Capital Partners, LP reported holding 750,000 shares of MLTX (MOONLAKE IMMUNOTHERAPEUTICS) in its Q2 2026 13F filing — a position valued at US$14.6M, representing 2.32% of its reported portfolio and ranking #19 among its reported holdings. Trails Edge Capital Partners, LP first reported this position in Q2 2026.

Latest position (Q2 2026)750.00K sh
Reported value held$14.60M
Portfolio Weight2.32%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Trails Edge Capital Partners, LP's MLTX position evolved

Trails Edge Capital Partners, LP first disclosed a stake in MLTX in Q2 2026 at 750,000 shares (US$14.6M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 750.00K $14.60M New

About MLTX and 13F data

MLTX (MOONLAKE IMMUNOTHERAPEUTICS) is a Health Care company. 29 other funds we track also report a position in MLTX — the largest reported positions include BVF INC/IL (US$311.5M), Deep Track Capital, LP (US$136.3M), Cormorant Asset Management, LP (US$62.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MLTX

All MLTX fund holders →

FAQ

How long has Trails Edge Capital Partners, LP held MLTX?

Trails Edge Capital Partners, LP has disclosed MLTX holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Trails Edge Capital Partners, LP's current position in MLTX?

As of Q2 2026, Trails Edge Capital Partners, LP holds 750.00K shares of MLTX (MOONLAKE IMMUNOTHERAPEUTICS), valued at $14.60M, representing 2.32% of its reported portfolio and ranking #19.

Has Trails Edge Capital Partners, LP been buying or selling MLTX?

In the latest 13F filing (Q2 2026), Trails Edge Capital Partners, LP newly opened its position in MLTX.

Which other funds hold MLTX?

Other major institutional holders of MLTX include BVF INC/IL, Deep Track Capital, LP, Cormorant Asset Management, LP, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.